6[2]Palomaki GE, Knight GJ, McCarthy JE, et al. Maternal serum screening for Down syndrome in the United States: A 1995 survey. AmJ Obstet Gynecol, 1997, 176: 1046-1051
7[3]Huderer Duric K, Skrablin S, Kuvacic I, et al. The triple- marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity. Eur J Obstet Gynecol Reprod boil, 2000, 88: 49- 55
8[4]WaldNJ, GeorgeL, SmithD, etal. Serum screening for Down syndrome between 8 and14 weeks of pregnancy. International Prenatal Screening Research Group. BrJ Obstet Gynecol, 1996, 103:407-412
9[5]Haddow JE, Palomaki GE, Knight GJ, et al. Screening of maternal serum for fetal Down's syndrome in the first trimester. New Engl J Med, 1998,338:955-961
10[6]Extermann P, Bischof P, Marguerat P, et al. Second - trimester maternal serum screening for Down's syndrome: free beta-human cborionic gonadotrophin (hCG) and alpha- fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha- fetoprotein and nuconjugated oestriol. Hum-Reprod, 1998, 13: 220-223
